Skip to content


Featured: How I read cancer imaging studies: the master class series

New Content ItemSurprisingly, in contrast to the literature regarding the outcomes of imaging, the methods that underpin the generation of an imaging report and how to communicate the findings cogently to referring clinicians remain something of a ‘black box'.

In this thematic series, experts across various modalities detail their approach to reporting scans in particular disease settings.  In the Editorial written by Prof Rodney Hicks, Co-Editor-in-Chief of Cancer Imaging, he details the motivation for this ‘master class series’ as well as his own approach to reporting.

Please click here to visit the series collection page.

Aims and scope

Cancer Imaging is an open access, peer-reviewed journal publishing original articles, reviews and editorials written by expert international radiologists working in oncology.

The journal encompasses CT, MR, PET, ultrasound, radionuclide and multimodal imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.  

Please click here for more information.


Most accessed articles RSS

View all articles

Call for Abstracts

New Content Item

The International Cancer Imaging Society Meeting and 18th Annual Teaching Course titled 'Advancing Cancer Imaging: Improving Patient Outcomes' will take place in France in October 2018.

Please submit your abstract and present your work at this international teaching course.  Accepted abstracts will be published in the Course Proceedings.

The deadline for abstract submissions is Monday 4th June 2018.

Please click here for further information.

APC discount for ICIS Members

If you are a member of the International Cancer Imaging Society (ICIS), you can receive a 20% article processing charge (APC) discount for publishing in Cancer Imaging. Please email: for details.


Prof Rodney Hicks, The Peter MacCallum Cancer Centre, Australia

Assoc. Prof Annick Van den Abbeele, Dana-Farber Cancer Institute, USA 

Editor's quote

A major focus of Prof Rodney Hicks' (Co-Editor-in-Chief of Cancer Imaging) clinical research has been to assess the impact of PET on patient management and prognostic stratification. 

R Hicks

"A few years ago I changed the name of my department from Diagnostic Imaging to Cancer Imaging since it occurred to me that little of what we do is diagnostic.  Increasingly, the role of imaging in cancer is in selecting, planning and monitoring treatment.  The challenge of imaging science is to establish our techniques as prognostic and predictive biomarkers and to show that our results improve patient outcomes"

Prof Rodney Hicks, Co-Editor-in-Chief, Cancer Imaging


2016 Journal Metrics